What does my licence allow?
Institutions may purchase online access to individual or multiple ERS publications titles for a single site or multi-site access.
Your licence outlines how and from where your library users can access our online content.
Permitted uses:
For the purposes of research, teaching and private study ONLY, authorised users may:
- electronically save portions of the licensed material. For reference purposes, 5% of a journal issue would be considered to be an acceptable ‘portion’
- print out a single copy of a portion of the licensed materials
- for users based within a subscribing pharmaceutical company, a print or electronic copy of the licensed material may be provided for use in national or international regulatory authority submissions
Prohibited uses:
Neither the licensee nor authorised users may:
- amend or remove any of the copyright information visible on the licensed content
- systematically make printed or electronic copies of multiple portions of the licensed content for any purpose
- display or distribute the licensed material on any other electronic network except for the secure network of the subscribing institution
- allow anyone else except authorised users to access the licensed content
- use the licensed content for any commercial purpose without permission from the publisher
What licences are available?
1. Single institutional licence
Single institutions are classed as being located within one metropolitan boundary with a single billing address for all subscription purchases. Pricing options are based around the current list price of the journals. By purchasing a subscription to any of our online publications, you agree to the ERS site licence agreement.
2. Multi-site licence
Pricing is based on consolidation of existing subscriptions (if any), plus any additional sites or titles that may be required. Billing is made to a single billing address on a single invoice.
If you are interested in purchasing a multi-site licence, please contact subscriptions@ersnet.org, detailing the ERS publication title(s) required, the number of sites with their full postal addresses, plus any relevant FTE/bed information at the individual sites.
3. Consortial licence
The ERS publications take part in consortial agreements in some territories via chosen partner sales agents. Licence prices and agreements are negotiated by the representative sales agents in each territory.
Other questions?
For any other questions relating to licensing, please contact subscriptions@ersnet.org
For information on using content for commercial purposes, please contact permissions@ersnet.org
Disclaimer of warranties
In no event shall the European Respiratory Society (ERS) or HighWire Press be liable for any special, incidental, indirect or consequential damages of any kind arising out of or in connection with the use of the articles or other material derived from the ERS publications online, whether or not advised of the possibility of damage, and on any theory of liability.
The ERS publications online are provided "as is" without warranty of any kind, either expressed or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, or non-infringement. Descriptions of, or references to, products or publications does not imply endorsement of that product or publication. WARRANTY: While the ERS seeks to ensure the accuracy of content posted online, it does not warrant or guarantee its accuracy, completeness, merchantability or fitness for a particular purpose. In no case shall the ERS liability for any content or accessibility problems with the site exceed the amount of subscription fees paid for the ERS publications online during the 6-month period preceding any claim or notice of damages.
The ERS publications online are under constant development and changes may be made in these publications and programs at any time. There is no guarantee that the information contained in the ERS publications online is identical to that in the print versions of the publications.
This page was updated on 8 February, 2019